Loading...

Comera Life Sciences Holdings, Inc.

CMRANASDAQ
Healthcare
Biotechnology
$0.00
$0.00(0.00%)

Comera Life Sciences Holdings, Inc. (CMRA) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.
EPS (TTM)
$-0.22
P/E Ratio
-
ROE
1.72%
Net Margin
-28.44%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$6.15K
Shares OutstandingTotal number of shares issued
$30.74M
Book Value/ShareNet worth per share
$-0.60
Revenue/ShareAnnual revenue per share
$0.06

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$-0.22
Net MarginNet income as percentage of revenue
-2843.79%
Operating MarginOperating income as percentage of revenue
-1890.69%
ROEReturn on shareholders' equity
172.01%
ROAReturn on total assets
-483.06%
ROCEReturn on capital employed
898.94%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$-0.94
Cash/ShareCash and equivalents per share
$0.04
FCF YieldFree cash flow as percentage of market cap
-159407.56%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
-
Dividend YieldAnnual dividend as percentage of stock price
-
Financial Ratios Analysis data is not available for CMRAFinancial Ratios Analysis details for CMRA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for CMRASector Benchmarking details for CMRA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Comera Life Sciences Holdings, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Comera Life Sciences Holdings, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Comera Life Sciences Holdings, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Comera Life Sciences Holdings, Inc.

For Comera Life Sciences Holdings, Inc., essential financial indicators include EPS -0.22, PE -, and ROE 1.72. These key ratios reveal insights into Comera Life Sciences Holdings, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Comera Life Sciences Holdings, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Comera Life Sciences Holdings, Inc.

Metrics like Net Margin -2843.79% and ROA -483.06% shed light on how well Comera Life Sciences Holdings, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Comera Life Sciences Holdings, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Comera Life Sciences Holdings, Inc.

Using ratios such as P/B Ratio -0.00 and PEG Ratio -0.00, investors can assess whether Comera Life Sciences Holdings, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Comera Life Sciences Holdings, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Comera Life Sciences Holdings, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.12 and Cash Flow $-0.94, provide a snapshot of Comera Life Sciences Holdings, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Comera Life Sciences Holdings, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Comera Life Sciences Holdings, Inc.

Investing in Comera Life Sciences Holdings, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Comera Life Sciences Holdings, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;